Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on sepsis treatment.

Journal of intensive care·2026
Same author

Use of Prokinetic Agents in Adult ICU Patients: An International Inception Cohort Study (PATIENCE).

Acta anaesthesiologica Scandinavica·2026
Same author

Innovation in sepsis trials: rethinking endpoints, statistics and patient stratification.

Intensive care medicine experimental·2026
Same author

Characterization and Outcomes of Septic Shock Patients with Macrophage Activation-Like Syndrome: Prognostic Role of Hyperferritinemia and Description of Hemoadsorption in Refractory Hyperinflammatory Septic Shock.

Blood purification·2026
Same author

Targeting Pseudomonas aeruginosa in Nosocomial Respiratory Infections: From Broad Empiricism to Precision Therapy.

Chest·2026
Same author

Publisher Correction: Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026.

Intensive care medicine·2026

Related Experiment Videos

Bloodstream infection in the ICU.

Jordi Vallés1, Ricard Ferrer

  • 1Critical Care Center, Hospital Sabadell, Institut Universitari Parc Taulí. UAB, CIBER Enfermedades Respiratorias, Parc Taulí s/n, Sabadell 08208, Spain. jvalles@tauli.cat

Infectious Disease Clinics of North America
|August 12, 2009
PubMed
Summary

Hospital-acquired infections (HAIs) are a major cause of illness and death. This article focuses on bloodstream infections (BSIs) in intensive care units (ICUs), where they are particularly common and severe.

Related Experiment Videos

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Hospital Epidemiology

Background:

  • Hospital-acquired infections (HAIs) affect 5%-10% of US patients, contributing significantly to morbidity and mortality.
  • Intensive care units (ICUs) disproportionately experience HAIs, accounting for 45% of hospital-acquired pneumonias and bloodstream infections (BSIs).
  • Factors contributing to high ICU infection rates include patient severity, invasive procedures, and resistant microorganisms.

Purpose of the Study:

  • To discuss the clinical significance of bloodstream infections (BSIs).
  • To review both hospital- and community-acquired BSIs within the ICU setting.
  • To highlight the critical nature of BSIs in intensive care.

Main Methods:

  • Literature review and clinical discussion.
  • Analysis of epidemiological data on HAIs.
  • Focus on BSI etiology and impact in ICUs.

Main Results:

  • HAIs are a significant cause of patient harm and mortality.
  • ICUs are high-risk environments for BSIs due to patient acuity and interventions.
  • Understanding BSI factors is crucial for effective management.

Conclusions:

  • Bloodstream infections (BSIs) represent a critical clinical challenge in ICUs.
  • Addressing risk factors in ICUs is essential to reduce BSI incidence and impact.
  • Comprehensive management strategies are needed for hospital- and community-acquired BSIs in critical care.